Analystreport

Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00.

iRadimed Corporation  (IRMD) 
Last iradimed corporation earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: iradimed.com/en-us/investors/investor-contact